Analyst Ratings For NASDAQ:MEIP – MEI Pharma (NASDAQ:MEIP)
Today, Laidlaw initiated coverage on NASDAQ:MEIP – MEI Pharma (NASDAQ:MEIP) with a Buy with a price target of $7.00.
Some recent analyst ratings include
- 4/12/2018-Laidlaw initiated coverage with a Buy rating.
- 3/21/2018-Cann Reiterated Rating of Buy.
- 8/2/2016-Wedbush Reiterated Rating of Neutral.
Recent Insider Trading Activity For NASDAQ:MEIP – MEI Pharma (NASDAQ:MEIP)
NASDAQ:MEIP – MEI Pharma (NASDAQ:MEIP) has insider ownership of 5.25% and institutional ownership of 23.51%.
- On 11/27/2017 Charles V Baltic III, Director, bought 11,000 with an average share price of $2.25 per share and the total transaction amounting to $24,750.00.
- On 11/9/2015 Vivo Ventures Vii, Llc, Major Shareholder, sold 390,572 with an average share price of $1.84 per share and the total transaction amounting to $718,652.48.
- On 1/21/2015 Charles V Baltic III, Director, bought 5,000 with an average share price of $3.81 per share and the total transaction amounting to $19,050.00.
- On 12/9/2014 Leaf Ventures Ii L.P. New, Major Shareholder, sold 79,085 with an average share price of $6.01 per share and the total transaction amounting to $475,300.85.
- On 12/8/2014 Leaf Ventures Ii L.P. New, Major Shareholder, sold 9,004 with an average share price of $6.05 per share and the total transaction amounting to $54,474.20.
- On 6/30/2014 Charles V Baltic III, Director, bought 2,000 with an average share price of $6.56 per share and the total transaction amounting to $13,120.00.
- On 10/29/2013 Vivo Ventures Vii, Llc, Major Shareholder, sold 299,609 with an average share price of $8.21 per share and the total transaction amounting to $2,459,789.89.
Recent Trading Activity for NASDAQ:MEIP – MEI Pharma (NASDAQ:MEIP)
Shares of NASDAQ:MEIP – MEI Pharma closed the previous trading session at 2.23 up +0.28 14.25% with shares trading hands.